Home Kocher, Michael

Michael Kocher

© Xellia Pharmaceuticals

CEO

Xellia Pharmaceuticals

speaker-image

© Xellia Pharmaceuticals

CEO

Xellia Pharmaceuticals

He became CEO of Xellia Pharmaceuticals in October 2023. Previously, he held positions at Sandoz and Novartis, including Head of Global B2B and Country President for Austria, bringing over a decade of experience in the pharmaceutical and anti-infectives sector.

Michael Kocher on the Schedule 2025

All times in CEST

Monday, 25. August

Starting times

Afternoon

Strengthening Europe’s Antibiotic Independence

Antibiotics are vital to modern medicine, yet Europe’s production capacity is at risk, with most API suppliers based in China. This dependency threatens security, competitiveness, and public health. This session will explore restoring Europe’s antibiotic capacity, reducing reliance, and strengthening sovereignty - key not only for health policy, but for supply security, competitiveness, and geopolitical stability.

Congress Centrum Alpbach , CCA – Loggia

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image

14:00 - 15:30 Strengthening Europe’s Antibiotic Independence

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image

speaker-image